Dr. Achillefs Ntranos, MD

Dr. Ntranos practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Ntranos' NPI, 1679913586, was assigned on June 25, 2013. Dr. Ntranos graduated from University of Athens in 2011. Dr. Ntranos holds California license C181399.

Dr. Ntranos' primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Ntranos' primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Ntranos is also affiliated with Cedars-Sinai Medical Center. The medical group on file is San Juan Health Partners Physiatry. Dmand AI also links Dr. Ntranos to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ntranos practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ntranos' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Ntranos is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Ntranos' licenses on file in 4 states: California, Florida, New Mexico and New York.

Dmand AI lists carpal tunnel syndrome and restless legs syndrome among the conditions Dr. Ntranos treats.

CMS data shows 211 Medicare services from Dr. Ntranos across 3 procedure codes in 2024, for 102 Medicare patients. Medicare paid $17,807 for them. Every service was in an office.

CMS counts 102 Medicare patients who saw Dr. Ntranos in 2024. The largest group is 65 to 74, with 46 patients. 63% of them have high cholesterol, and 62% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ntranos' median patient age at 63, with 63% women.

In 2024, Dr. Ntranos wrote 295 Medicare Part D claims for 80 patients. 93% of them were for generic drugs. CMS names the drug for 134 of them, across 6 drugs with 11 or more claims each, at $2,292 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ntranos for performance year 2024, reported as part of a group. CMS lists Dr. Ntranos as offering telehealth.

Dmand AI links Dr. Ntranos to 1 clinical trial. Conditions studied include Vitamin D Deficiency and Avitaminosis.

CMS Open Payments shows 10 general payments to Dr. Ntranos from 6 drug and device companies from 2018 to 2024. Consulting fees make up the largest share, 91% of the total. Biogen, Inc. paid the most, $3,791.

Dmand AI lists 4 awards for Dr. Ntranos, most recently Chief Resident in Neurology in 2016.

Dr. Ntranos graduated from University of Athens in 2011. Dr. Ntranos is a member of Americal Association of Immunologists, AAN, American Neurological Association and American Physician Scientist Association.

Dr. Ntranos is in network with 4 carriers, including Aetna, Molina and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.